These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26145249)

  • 101. A review on host-pathogen interactions: classification and prediction.
    Sen R; Nayak L; De RK
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1581-99. PubMed ID: 27470504
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Diagnosing and Managing Sepsis by Probing the Host Response to Infection: Advances, Opportunities, and Challenges.
    Gunsolus IL; Sweeney TE; Liesenfeld O; Ledeboer NA
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31043466
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The use of proteomics to study infectious diseases.
    List EO; Berryman DE; Bower B; Sackmann-Sala L; Gosney E; Ding J; Okada S; Kopchick JJ
    Infect Disord Drug Targets; 2008 Mar; 8(1):31-45. PubMed ID: 18473905
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Isotopic biomarker discovery and application in translational medicine.
    Bayele HK; Chiti A; Colina R; Fernandes O; Khan B; Krishnamoorthy R; Ozdağ H; Padua RA
    Drug Discov Today; 2010 Feb; 15(3-4):127-36. PubMed ID: 20038454
    [TBL] [Abstract][Full Text] [Related]  

  • 105. New views on the Malpighian tubule from post-genomic technologies.
    Dow JA; Pandit A; Davies SA
    Curr Opin Insect Sci; 2018 Oct; 29():7-11. PubMed ID: 30551828
    [TBL] [Abstract][Full Text] [Related]  

  • 106. New technologies personalize diagnostics and therapeutics.
    Rosenson RS
    Curr Atheroscler Rep; 2010 May; 12(3):184-6. PubMed ID: 20425257
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Detecting specific infections in children through host responses: a paradigm shift.
    Mejias A; Suarez NM; Ramilo O
    Curr Opin Infect Dis; 2014 Jun; 27(3):228-35. PubMed ID: 24739346
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Biomarkers in Infectious Diseases.
    Hwang H; Hwang BY; Bueno J
    Dis Markers; 2018; 2018():8509127. PubMed ID: 30026882
    [No Abstract]   [Full Text] [Related]  

  • 109. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.
    Lozupone M; Seripa D; Stella E; La Montagna M; Solfrizzi V; Quaranta N; Veneziani F; Cester A; Sardone R; Bonfiglio C; Giannelli G; Bisceglia P; Bringiotti R; Daniele A; Greco A; Bellomo A; Logroscino G; Panza F
    Expert Rev Proteomics; 2017 Sep; 14(9):809-824. PubMed ID: 28870126
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Empowering thyroid hormone research in human subjects using OMICs technologies.
    Pietzner M; Kacprowski T; Friedrich N
    J Endocrinol; 2018 Jul; 238(1):R13-R29. PubMed ID: 29724864
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Applying Genomics and Proteomics in Translational Surgical Oncology Research.
    Gemoll T; Meyer R; Habermann JK
    Eur Surg Res; 2015; 55(3):184-97. PubMed ID: 26339997
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.
    Ray S; Patel SK; Kumar V; Damahe J; Srivastava S
    Proteomics Clin Appl; 2014 Feb; 8(1-2):53-72. PubMed ID: 24293340
    [TBL] [Abstract][Full Text] [Related]  

  • 113. HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach.
    Ward B; Yombi JC; Balligand JL; Cani PD; Collet JF; de Greef J; Dewulf JP; Gatto L; Haufroid V; Jodogne S; Kabamba B; Pyr Dit Ruys S; Vertommen D; Elens L; Belkhir L
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891354
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Application of Multiplex Biomarker Approaches to Accelerate Drug Discovery and Development.
    Rahmoune H; Guest PC
    Methods Mol Biol; 2017; 1546():3-17. PubMed ID: 27896754
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Advances in microfluidics in combating infectious diseases.
    Tay A; Pavesi A; Yazdi SR; Lim CT; Warkiani ME
    Biotechnol Adv; 2016; 34(4):404-421. PubMed ID: 26854743
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Precision Medicine for Neonatal Sepsis.
    Ng S; Strunk T; Jiang P; Muk T; Sangild PT; Currie A
    Front Mol Biosci; 2018; 5():70. PubMed ID: 30094238
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [Proteomics in infectious diseases].
    Quero S; Párraga-Niño N; García-Núñez M; Sabrià M
    Enferm Infecc Microbiol Clin; 2016 Apr; 34(4):253-60. PubMed ID: 25583331
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Synthetic Biology-Based Point-of-Care Diagnostics for Infectious Disease.
    Wei TY; Cheng CM
    Cell Chem Biol; 2016 Sep; 23(9):1056-1066. PubMed ID: 27662252
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The importance of models of infection in the study of disease resistance.
    Druilhe P; Hagan P; Rook GA
    Trends Microbiol; 2002; 10(10 Suppl):S38-46. PubMed ID: 12377567
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm.
    Aderem A; Adkins JN; Ansong C; Galagan J; Kaiser S; Korth MJ; Law GL; McDermott JG; Proll SC; Rosenberger C; Schoolnik G; Katze MG
    mBio; 2011 Mar; 2(1):e00325-10. PubMed ID: 21285433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.